Related Experiment Video
Updated: Feb 11, 2026

A RANKL-based Osteoclast Culture Assay of Mouse Bone Marrow to Investigate the Role of mTORC1 in Osteoclast Formation
Published on: March 15, 2018
Role of Muramyl Dipeptide in Lipopolysaccharide-Mediated Biological Activity and Osteoclast Activity
Hideki Kitaura1, Masahiko Ishida1, Keisuke Kimura1
1Division of Orthodontics and Dentofacial Orthopedics, Department of Translational Medicine, Tohoku University Graduate School of Dentistry, 4-1 Seiryo-machi, Aoba-ku, Sendai 980-8575, Japan.
Abstract:
Lipopolysaccharide (LPS) is an endotoxin and bacterial cell wall component that is capable of inducing inflammation and immunological activity. Muramyl dipeptide (MDP), the minimal essential structural unit responsible for the immunological activity of peptidoglycans, is another inflammation-inducing molecule that is ubiquitously expressed by bacteria. Several studies have shown that inflammation-related biological activities were synergistically induced by interactions between LPS and MDP. MDP synergistically enhances production of proinflammatory cytokines that are induced by LPS exposure. Injection of MDP induces lethal shock in mice challenged with LPS. LPS also induces osteoclast formation and pathological bone resorption; MDP enhances LPS induction of both processes. Furthermore, MDP enhances the LPS-induced receptor activator of NF-κB ligand (RANKL) expression and toll-like receptor 4 (TLR4) expression both in vivo and in vitro. Additionally, MDP enhances LPS-induced mitogen-activated protein kinase (MAPK) signaling in stromal cells. Taken together, these findings suggest that MDP plays an important role in LPS-induced biological activities. This review discusses the role of MDP in LPS-mediated biological activities, primarily in relation to osteoclastogenesis.
Insights
Muramyl dipeptide (MDP) amplifies lipopolysaccharide (LPS)-induced inflammation and bone resorption. MDP enhances LPS effects on cytokine production, shock, and osteoclastogenesis, highlighting its critical role in LPS-mediated biological activities.
Area of Science:
- Immunology
- Microbiology
- Cell Biology
Background:
- Lipopolysaccharide (LPS) is a bacterial endotoxin that triggers inflammation and immune responses.
- Muramyl dipeptide (MDP) is a key component of peptidoglycans, also inducing inflammation.
- Synergistic interactions between LPS and MDP amplify inflammatory and immunological activities.
Purpose of the Study:
- To review the role of MDP in LPS-mediated biological activities.
- To focus on MDP's influence on LPS-induced osteoclastogenesis.
- To elucidate the mechanisms by which MDP enhances LPS effects.
Main Methods:
- Literature review of studies investigating LPS and MDP interactions.
- Analysis of data on cytokine production, shock induction, and bone resorption.
- Examination of molecular signaling pathways including TLR4, RANKL, and MAPK.
Main Results:
- MDP synergistically enhances LPS-induced proinflammatory cytokine production.
- MDP exacerbates LPS-induced lethal shock in mice.
- MDP potentiates LPS-driven osteoclast formation, bone resorption, RANKL, TLR4 expression, and MAPK signaling.
Conclusions:
- MDP significantly enhances various LPS-mediated biological activities.
- MDP plays a crucial role in LPS-induced osteoclastogenesis and bone pathology.
- Understanding MDP-LPS interactions is vital for targeting inflammatory and bone diseases.
Related Concept Videos
Activation Energy
Eukaryotic Transcription Activators
The binding domains are capable of recognizing and interacting with regulatory sequences on the DNA. These...
Role of Water in Human Biology
Water's Solvent Properties
Since water is a polar molecule with slightly positive and slightly negative charges, ions and polar molecules can readily dissolve in it. Therefore, it is referred to as a solvent, a...
Co-activators and Co-repressors
tRNA Activation
Secondary Active Transport

